Federation des caisses Desjardins du Quebec’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $103K | Sell |
808
-3,395
| -81% | -$424K | ﹤0.01% | 1683 |
|
|
2025
Q4 | $512K | Buy |
4,203
+3,608
| +606% | +$414K | ﹤0.01% | 1279 |
|
|
2025
Q3 | $59.6K | Hold |
595
| – | – | ﹤0.01% | 1771 |
|
|
2025
Q2 | $49.3K | Sell |
595
-261
| -30% | -$20.8K | ﹤0.01% | 1565 |
|
|
2025
Q1 | $69.4K | Sell |
856
-76
| -8% | -$6.79K | ﹤0.01% | 1394 |
|
|
2024
Q4 | $83.9K | Sell |
932
-179
| -16% | -$17.3K | ﹤0.01% | 1306 |
|
|
2024
Q3 | $110K | Hold |
1,111
| – | – | ﹤0.01% | 1237 |
|
|
2024
Q2 | $103K | Sell |
1,111
-25
| -2% | -$2.24K | ﹤0.01% | 1239 |
|
|
2024
Q1 | $108K | Buy |
1,136
+366
| +48% | +$34K | ﹤0.01% | 1216 |
|
|
2023
Q4 | $68.8K | Sell |
770
-2,385
| -76% | -$177K | ﹤0.01% | 1216 |
|
|
2023
Q3 | $230K | Buy |
3,155
+14
| +0.4% | +$1.12K | ﹤0.01% | 919 |
|
|
2023
Q2 | $261K | Sell |
3,141
-10
| -0.3% | -$836 | ﹤0.01% | 903 |
|
|
2023
Q1 | $240K | Hold |
3,151
| – | – | ﹤0.01% | 910 |
|
|
2022
Q4 | $262K | Sell |
3,151
-980
| -24% | -$79.3K | ﹤0.01% | 952 |
|
|
2022
Q3 | $328K | Buy |
4,131
+1,000
| +32% | +$84.3K | ﹤0.01% | 900 |
|
|
2022
Q2 | $233K | Hold |
3,131
| – | – | ﹤0.01% | 1060 |
|
|
2022
Q1 | $281K | Sell |
3,131
-822
| -21% | -$75.9K | ﹤0.01% | 1053 |
|
|
2021
Q4 | $443K | Buy |
3,953
+2,150
| +119% | +$259K | ﹤0.01% | 885 |
|
|
2021
Q3 | $227K | Sell |
1,803
-850
| -32% | -$109K | ﹤0.01% | 1134 |
|
|
2021
Q2 | $359K | Sell |
2,653
-260
| -9% | -$34.2K | ﹤0.01% | 994 |
|
|
2021
Q1 | $395K | Buy |
2,913
+100
| +4% | +$15K | ﹤0.01% | 899 |
|
|
2020
Q4 | $396K | Buy |
2,813
+357
| +15% | +$45.7K | ﹤0.01% | 846 |
|
|
2020
Q3 | $274K | Buy |
2,456
+396
| +19% | +$44.4K | ﹤0.01% | 793 |
|
|
2020
Q2 | $231K | Sell |
2,060
-1,500
| -42% | -$148K | ﹤0.01% | 807 |
|
|
2020
Q1 | $276K | Sell |
3,560
-715
| -17% | -$63.3K | ﹤0.01% | 778 |
|
|
2019
Q4 | $407K | Buy |
4,275
+1,215
| +40% | +$105K | 0.01% | 827 |
|
|
2019
Q3 | $233K | Sell |
3,060
-1,100
| -26% | -$91.4K | ﹤0.01% | 998 |
|
|
2019
Q2 | $365K | Sell |
4,160
-1,000
| -19% | -$85.3K | 0.01% | 860 |
|
|
2019
Q1 | $467K | Buy |
5,160
+1,300
| +34% | +$111K | 0.01% | 760 |
|
|
2018
Q4 | $277K | Sell |
3,860
-1,000
| -21% | -$80.6K | ﹤0.01% | 861 |
|
|
2018
Q3 | $466K | Sell |
4,860
-1,350
| -22% | -$131K | 0.01% | 766 |
|
|
2018
Q2 | $591K | Sell |
6,210
-1,125
| -15% | -$103K | 0.01% | 728 |
|
|
2018
Q1 | $644K | Sell |
7,335
-250
| -3% | -$22.8K | 0.01% | 697 |
|
|
2017
Q4 | $644K | Sell |
7,585
-2,950
| -28% | -$247K | 0.01% | 701 |
|
|
2017
Q3 | $912K | Buy |
10,535
+1,450
| +16% | +$116K | 0.01% | 628 |
|
|
2017
Q2 | $701K | Buy |
9,085
+2,279
| +33% | +$162K | 0.01% | 666 |
|
|
2017
Q1 | $472K | Buy |
+6,806
| New | +$457K | 0.01% | 681 |
|
Other funds holding XBI
Federation des caisses Desjardins du Quebec's XBI Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 81% in Q1 2026, selling an estimated $424K and leaving 808 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.
Federation des caisses Desjardins du Quebec first reported a position in XBI in Q1 2017 and has held it in 37 quarters since. The position peaked at $912K in Q3 2017. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 808 shares of State Street SPDR S&P Biotech ETF worth $103K as of Q1 2026.
- Federation des caisses Desjardins du Quebec sold 3,395 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $424K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1683 holding.
- Federation des caisses Desjardins du Quebec first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 37 quarters since.
- Federation des caisses Desjardins du Quebec's State Street SPDR S&P Biotech ETF position peaked at $912K in Q3 2017.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.